An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs. Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

  • Gurney, Howard (Primary Chief Investigator)
  • Cunningham, Jacob, (Research Coordinator)
  • Butala, Radhika, (Research Coordinator)

Project: Other

Project Details

Short title7465-CL-0301
StatusActive
Effective start/end date15/09/188/06/23